Claret Medical Overview

  • Founded

  • 2009

Founded
  • Status

  • Acquired/​Merged

  • Employees

  • 120

Employees
  • Latest Deal Type

  • M&A

  • Latest Deal Amount

  • $270M

Claret Medical General Information

Description

Developer of a cerebral protection system designed to reduce the risk of stroke during transcatheter aortic valve replacement (TAVR). The company's cerebral protection system offers endovascular technology and cerebral vascular-protection systems for transcatheter aortic valve implantation and surgical aortic valve replacement, enabling medical institutes to capture and remove debris dislodged during TAVR procedures, preventing it from traveling to the brain where it may cause injury.

Contact Information

Website
www.claretmedical.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Surgical Devices
Acquirer
Boston Scientific
Primary Office
  • 1745 Copperhill Parkway
  • Suite 1
  • Santa Rosa, CA 95403
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Claret Medical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 02-Aug-2018 $270M 0000 00000 Completed Generating Revenue
6. Later Stage VC (Series C) 01-Oct-2017 000.00 0000 000.00 Completed Generating Revenue
5. Early Stage VC (Series B2) 03-Jun-2016 000 000.00 000.00 Completed Generating Revenue
4. Debt - General 03-Mar-2016 00.00 000.00 Completed Generating Revenue
3. Early Stage VC (Series B) 01-Apr-2015 000.00 000.00 000.00 Completed Generating Revenue
2. Early Stage VC (Series A) 24-Aug-2011 $4.33M $4.33M 000.00 Completed Startup
1. Corporate 01-Jan-2009 Completed Startup
To view Claret Medical’s complete valuation and funding history, request access »

Claret Medical Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series C 00,000,000 00.000000 00 00.00 00.00 00 00.00 000
Series B-2 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series B-1 20,271,214 $0.000010 8% $0.39 $0.39 1x $0.33 13.46%
Series A 4,779,181 $0.000010 8% $1 $1 1x $0.33 8.24%
To view Claret Medical’s complete cap table history, request access »

Claret Medical Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a cerebral protection system designed to reduce the risk of stroke during transcatheter aortic valve replac
Surgical Devices
Santa Rosa, CA
120 As of 2018
0000
0000 0000-00-00
000000&0 0000

0000 0

nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit
00000000 0000000
Amiens, France
0 As of 0000
00.000
000000000 00.000

000000

t esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat
00000000 0000000
Tampa, FL
000.00
000000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Claret Medical Competitors (16)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Open Stent Solution Venture Capital-Backed Amiens, France 0 00.000 000000000 00.000
00000000 00000 Private Equity-Backed Tampa, FL 000.00 000000000000 000.00
000 (00000000 0000 Venture Capital-Backed Grand Rapids, MI 0000 0000000000 0000
00000000 Venture Capital-Backed Santa Cruz, CA 0 0000 00000000000 0000
0000000 0000000 Venture Capital-Backed Kadima, Israel 00 00000 0000000000 0 00000
You’re viewing 5 of 16 competitors. Get the full list »

Claret Medical Patents

  • 44

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 6

    Granted

  • 1

    Pending

  • 000

    Expiring in next 12 mo

Claret Medical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-11382441-B2 Portable filter Active 26-Apr-2019 000000000 0
US-20200337486-A1 Portable filter Active 26-Apr-2019 000000000
US-20190183628-A1 Systems for protection of the cerebral vasculature during a cardiac procedure Active 19-Dec-2017 000000000
US-20220039936-A1 Systems and methods for protecting the cerebral vasculature Pending 19-Dec-2017 000000000
EP-3727192-B1 System for protecting the cerebral vasculature Active 19-Dec-2017 A61F2/011 0
To view Claret Medical’s complete patent history, request access »

Claret Medical Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Claret Medical Former Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Easton Capital Investment Group Venture Capital Minority 000 0000 000000 0
Gore Range Capital Venture Capital Minority 000 0000 000000 0
HealthCor Partners Management Growth/Expansion Minority 000 0000 000000 0
Incept VC-Backed Company Minority 000 0000 000000 0
Lightstone Ventures Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »

Ready to get started?

Request a free trial